Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1627
This examiner grants 68% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18251084 | CRYSTALLINE FORM I OF MELANOCORTIN RECEPTOR AGONIST COMPOUND AND PREPARATION METHOD THEREFOR | Final Rejection | LG CHEM, LTD. |
| 17791110 | A METHOD OF TREATMENT IN PREDISPOSED SUBJECTS FOR LMNA-RELATED DILATED CARDIOMYOPATHY | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18065348 | CANCER TREATMENT BY COMBINED INHIBITION OF POLO-LIKE KINASE AND MICROTUBULE POLYMERIZATION | Non-Final OA | Massachusetts Institute of Technology |
| 18551699 | NOVEL CYCLOPENTA[C]PYRROL NEGATIVE ALLOSTERIC MODULATORS OF NR2B | Non-Final OA | Novartis AG |
| 18756960 | ITRACONAZOLE ANALOGS AND USE THEREOF | Non-Final OA | The Johns Hopkins University |
| 18263205 | LIMONENE EFFECTS ON TETRAHYDROCANNABINOL (THC)-INDUCED ANXIETY | Non-Final OA | CReDO Science, LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy